Options: Hide MedDRA Preferred Terms
MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels |
---|---|---|---|---|
1 | ||||
Menopausal symptoms | Hot flush | 79% | x | |
Hot flush | Hot flush | 79% | x | |
Sleep disorder | Sleep disturbance | 44.4% | x | |
Pain | Pain | 30.9% | x | |
Breast enlargement | Breast enlargement | 29.6% | x | |
Breast pain | Breast pain | 19.8% | x | |
Nipple pain | Nipple tenderness | 19.8% | x | |
Back pain | Back pain | 17.3% | x | |
Constipation | Constipation | 14.8% | x | |
Oedema peripheral | Oedema peripheral | 14.8% | x | |
Dizziness | Dizziness | 12.3% | x | |
Headache | Headache | 12.3% | x | |
Upper respiratory tract infection | Upper respiratory tract infection | 12.3% | x | |
Diarrhoea | Diarrhoea | 11.1% | x | |
Dysuria | Dysuria | 9.88% | x | |
Asthenia | Fatigue | 9.88% | x | |
Fatigue | Fatigue | 9.88% | x | |
Nausea | Nausea | 9.88% | x | |
Pollakiuria | Pollakiuria | 9.88% | x | |
Urinary tract infection | Urinary tract infection | 9.88% | x | |
Urinary retention | Urinary retention | 9.88% | x | |
Hypersensitivity | Hypersensitivity | x | ||
Blood triglycerides increased | Serum triglycerides increased | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Prostate cancer | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |